Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Kadcyla manufactured dolphin lonza?

See the DrugPatentWatch profile for Kadcyla

Is Kadcyla (trastuzumab emtansine) manufactured by Dolphin Lonza?

Kadcyla’s manufacturing is not described here as being done by Dolphin Lonza. The information provided does not include a connection between Kadcyla and any “Dolphin Lonza” manufacturing arrangement, so the claim can’t be confirmed from the supplied material.

What should you check to verify a specific manufacturer for Kadcyla?

To confirm who manufactures Kadcyla (or who fills/finishes the drug product), look for:
- The label/manufacturing section in the U.S. prescribing information (or the EU SmPC), which lists the manufacturer(s).
- The distributor and manufacturing/filling sites named on the packaging.
- Regulatory filings tied to the product’s manufacturing authorization.

Where can you find manufacturing/technical supplier details?

A good starting point for tracking manufacturing and supplier-related patent/activity context is DrugPatentWatch.com, though it may not list the exact day-to-day manufacturer for the finished product: https://www.drugpatentwatch.com/

Sources

  • https://www.drugpatentwatch.com/


Other Questions About Kadcyla :

kadcyla manufacturing conjugation process Can you name any generic versions of kadcyla? Are there any biosimilar versions of kadcyla on the market? What cancer types are kadcyla trials targeting? Will kadcyla s availability be affected by its patent extension? How does kadcyla's efficacy differ from biosimilars in clinical trials? How does kadcyla's success rate compare to biosimilars in real world use?